_id
69105501ccc777a4e85d55a7
Ticker
CRPGF
Name
Integrated Cannabis Company Inc
Exchange
PINK
Address
China Resources Building, Wan Chai, Hong Kong
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.crpharm.com
Description
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Last Close
0.56
Volume
300
Current Price
0.56
Change
0
Last Updated
2026-01-02T12:00:33.779Z
Image
-
Ipo Date
-
Market Cap
3518205696
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2018-04-30
Revenue
0
Cost Of Revenue
0
Gross Profit
0
Operating Expenses
58503
Operating Income
-58503
Interest Expense
-
Pretax Income
-61488
Net Income
-61488
Eps
-
Dividends Per Share
-
Shares Outstanding
6282510461
Income Tax Expense
0
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-2985
Cash
2696292
Short Term Investments
-
Receivables
895575
Inventories
-
Total Current Assets
3738746
Property Plant Equipment
-
Total Assets
3738746
Payables
-
Short Term Debt
18008
Long Term Debt
-
Total Liabilities
41923
Equity
3696823
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
-40386
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-40385
Cf_currency_symbol
USD
PE
7
PB
-
ROE
-1.663265998940171
ROA
-1.6446156010598205
FCF
-40386
Fcf Percent
-
Piotroski FScore
1
Health Score
44
Deep Value Investing Score
5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2018-04-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
58503
Quarters > 0 > income Statement > operating Income
-58503
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-61488
Quarters > 0 > income Statement > net Income
-61488
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2985
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
2696292
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
895575
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
3738746
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
3738746
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
18008
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
41923
Quarters > 0 > balance Sheet > equity
3696823
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-61488
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-40386
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-40385
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-1.663265998940171
Quarters > 0 > ratios > ROA
-1.6446156010598205
Quarters > 0 > ratios > FCF
-40386
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
44
Quarters > 1 > quarter
2018-01-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
30016
Quarters > 1 > income Statement > operating Income
-30016
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-36912
Quarters > 1 > income Statement > net Income
-36912
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-6896
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2736677
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
894260
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3793566
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
3793566
Quarters > 1 > balance Sheet > payables
28736
Quarters > 1 > balance Sheet > short Term Debt
18008
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
35255
Quarters > 1 > balance Sheet > equity
3758311
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-36912
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-247727
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-375735
Quarters > 1 > cash Flow > cash From Financing
198749
Quarters > 1 > cash Flow > net Change In Cash
-424713
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-0.9821433085234298
Quarters > 1 > ratios > ROA
-0.9730158905894876
Quarters > 1 > ratios > FCF
-247727
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2017-10-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
28659
Quarters > 2 > income Statement > operating Income
-28659
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-48800
Quarters > 2 > income Statement > net Income
-48800
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-20141
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3161390
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
515649
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3677039
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
3677039
Quarters > 2 > balance Sheet > payables
57189
Quarters > 2 > balance Sheet > short Term Debt
18008
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
73723
Quarters > 2 > balance Sheet > equity
3603316
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-48800
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-34809
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-260035
Quarters > 2 > cash Flow > cash From Financing
2050318
Quarters > 2 > cash Flow > net Change In Cash
1755474
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-1.3543080873284497
Quarters > 2 > ratios > ROA
-1.3271548112489424
Quarters > 2 > ratios > FCF
-34809
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
44
Quarters > 3 > quarter
2017-07-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
0
Quarters > 3 > income Statement > operating Expenses
50518
Quarters > 3 > income Statement > operating Income
-50518
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-54526
Quarters > 3 > income Statement > net Income
-54526
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-4008
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1405916
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
254038
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1659954
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1659954
Quarters > 3 > balance Sheet > payables
46504
Quarters > 3 > balance Sheet > short Term Debt
868008
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
908156
Quarters > 3 > balance Sheet > equity
751798
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-54526
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-51198
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-250715
Quarters > 3 > cash Flow > cash From Financing
1708376
Quarters > 3 > cash Flow > net Change In Cash
1406463
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-7.252746083389421
Quarters > 3 > ratios > ROA
-3.284789819476925
Quarters > 3 > ratios > FCF
-51198
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-07-31
Annuals > 0 > income Statement > revenue
257673256000
Annuals > 0 > income Statement > cost Of Revenue
216984387000
Annuals > 0 > income Statement > gross Profit
40688869000
Annuals > 0 > income Statement > operating Expenses
243867990000
Annuals > 0 > income Statement > operating Income
13805266000
Annuals > 0 > income Statement > interest Expense
2281882000
Annuals > 0 > income Statement > pretax Income
10929922000
Annuals > 0 > income Statement > net Income
3350857000
Annuals > 0 > income Statement > eps
0.5333627410254462
Annuals > 0 > income Statement > dividends Per Share
1488955000
Annuals > 0 > income Statement > shares Outstanding
6282510461
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
5.357663505443499
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
16424739000
Annuals > 0 > balance Sheet > short Term Investments
28211657000
Annuals > 0 > balance Sheet > receivables
81559141000
Annuals > 0 > balance Sheet > inventories
37052579000
Annuals > 0 > balance Sheet > total Current Assets
185845579000
Annuals > 0 > balance Sheet > property Plant Equipment
26339224000
Annuals > 0 > balance Sheet > total Assets
257760320000
Annuals > 0 > balance Sheet > payables
58786432000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
22863886000
Annuals > 0 > balance Sheet > total Liabilities
159673042000
Annuals > 0 > balance Sheet > equity
48244236000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
3350857000
Annuals > 0 > cash Flow > depreciation
3356710000
Annuals > 0 > cash Flow > change In Working Capital
2833476000
Annuals > 0 > cash Flow > cash From Operations
17535514000
Annuals > 0 > cash Flow > capital Expenditures
3202827000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-8190711000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.5333627410254462
Annuals > 0 > ratios > PB
0.07292489527992525
Annuals > 0 > ratios > ROE
6.945611077766886
Annuals > 0 > ratios > ROA
1.2999894630794995
Annuals > 0 > ratios > FCF
14332687000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.05562349474095209
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2023-07-31
Annuals > 1 > income Statement > revenue
244703884000
Annuals > 1 > income Statement > cost Of Revenue
206366398000
Annuals > 1 > income Statement > gross Profit
38337486000
Annuals > 1 > income Statement > operating Expenses
231877178000
Annuals > 1 > income Statement > operating Income
12826706000
Annuals > 1 > income Statement > interest Expense
2386312000
Annuals > 1 > income Statement > pretax Income
9880227000
Annuals > 1 > income Statement > net Income
3854247000
Annuals > 1 > income Statement > eps
0.6134883537283456
Annuals > 1 > income Statement > dividends Per Share
879965000
Annuals > 1 > income Statement > shares Outstanding
6282510461
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
5.241725546129868
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
24650670000
Annuals > 1 > balance Sheet > short Term Investments
34615717000
Annuals > 1 > balance Sheet > receivables
67663842000
Annuals > 1 > balance Sheet > inventories
31875487000
Annuals > 1 > balance Sheet > total Current Assets
178567830000
Annuals > 1 > balance Sheet > property Plant Equipment
25376401000
Annuals > 1 > balance Sheet > total Assets
246770296000
Annuals > 1 > balance Sheet > payables
54451021000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
15092478000
Annuals > 1 > balance Sheet > total Liabilities
153795482000
Annuals > 1 > balance Sheet > equity
45959605000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
4177523820
Annuals > 1 > cash Flow > depreciation
3164365000
Annuals > 1 > cash Flow > change In Working Capital
1601420000
Annuals > 1 > cash Flow > cash From Operations
15549886000
Annuals > 1 > cash Flow > capital Expenditures
3132715000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
9417280000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
0.6134883537283456
Annuals > 1 > ratios > PB
0.07654995855947849
Annuals > 1 > ratios > ROE
8.38616215261206
Annuals > 1 > ratios > ROA
1.5618763937455422
Annuals > 1 > ratios > FCF
12417171000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.050743661265303004
Annuals > 1 > health Score
42
Annuals > 2 > quarter
2022-07-31
Annuals > 2 > income Statement > revenue
218182994000
Annuals > 2 > income Statement > cost Of Revenue
184563943000
Annuals > 2 > income Statement > gross Profit
33619051000
Annuals > 2 > income Statement > operating Expenses
205316520000
Annuals > 2 > income Statement > operating Income
12866474000
Annuals > 2 > income Statement > interest Expense
2453466000
Annuals > 2 > income Statement > pretax Income
8361081000
Annuals > 2 > income Statement > net Income
3500270000
Annuals > 2 > income Statement > eps
0.5571451128857897
Annuals > 2 > income Statement > dividends Per Share
813072000
Annuals > 2 > income Statement > shares Outstanding
6282510461
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
5.897102136200404
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
15223726000
Annuals > 2 > balance Sheet > short Term Investments
31298695000
Annuals > 2 > balance Sheet > receivables
59723151000
Annuals > 2 > balance Sheet > inventories
26546652000
Annuals > 2 > balance Sheet > total Current Assets
152259493000
Annuals > 2 > balance Sheet > property Plant Equipment
22092419000
Annuals > 2 > balance Sheet > total Assets
215534373000
Annuals > 2 > balance Sheet > payables
48711224000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
9041903000
Annuals > 2 > balance Sheet > total Liabilities
134977029000
Annuals > 2 > balance Sheet > equity
43557034000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
4147412000
Annuals > 2 > cash Flow > depreciation
2558441000
Annuals > 2 > cash Flow > change In Working Capital
-601917000
Annuals > 2 > cash Flow > cash From Operations
10821138000
Annuals > 2 > cash Flow > capital Expenditures
2740062000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
875829000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
0.5571451128857897
Annuals > 2 > ratios > PB
0.08077239277036173
Annuals > 2 > ratios > ROE
8.036061408589024
Annuals > 2 > ratios > ROA
1.6239961873737885
Annuals > 2 > ratios > FCF
8081076000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.03703806539569257
Annuals > 2 > health Score
41
Annuals > 3 > quarter
2021-07-31
Annuals > 3 > income Statement > revenue
193564322642.16
Annuals > 3 > income Statement > cost Of Revenue
164644632232.93
Annuals > 3 > income Statement > gross Profit
28919690409.23
Annuals > 3 > income Statement > operating Expenses
182848188560.15
Annuals > 3 > income Statement > operating Income
10716134082
Annuals > 3 > income Statement > interest Expense
2243490196.55
Annuals > 3 > income Statement > pretax Income
6873015392.44
Annuals > 3 > income Statement > net Income
3080673318.09
Annuals > 3 > income Statement > eps
0.49035705347630143
Annuals > 3 > income Statement > dividends Per Share
616236184.15
Annuals > 3 > income Statement > shares Outstanding
6282510461
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
5.536213459032316
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
HKD
Annuals > 3 > balance Sheet > cash
14315973000
Annuals > 3 > balance Sheet > short Term Investments
32909786000
Annuals > 3 > balance Sheet > receivables
63450152000
Annuals > 3 > balance Sheet > inventories
24272942000
Annuals > 3 > balance Sheet > total Current Assets
144396250000
Annuals > 3 > balance Sheet > property Plant Equipment
20471213000
Annuals > 3 > balance Sheet > total Assets
203224875000
Annuals > 3 > balance Sheet > payables
61764276000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
5871382000
Annuals > 3 > balance Sheet > total Liabilities
125565613000
Annuals > 3 > balance Sheet > equity
41358938000
Annuals > 3 > balance Sheet > currency_symbol
CNY
Annuals > 3 > cash Flow > net Income
3768889000
Annuals > 3 > cash Flow > depreciation
2306600494.1
Annuals > 3 > cash Flow > change In Working Capital
245478614.4
Annuals > 3 > cash Flow > cash From Operations
10497405556.29
Annuals > 3 > cash Flow > capital Expenditures
2571231505
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
5441465506.25
Annuals > 3 > cash Flow > currency_symbol
CNY
Annuals > 3 > ratios > PE
0.49035705347630143
Annuals > 3 > ratios > PB
0.08506518852490846
Annuals > 3 > ratios > ROE
7.448627714014321
Annuals > 3 > ratios > ROA
1.5158938186528592
Annuals > 3 > ratios > FCF
7926174051.290001
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.040948527823193026
Annuals > 3 > health Score
41
Valuation > metrics > PE
7
Valuation > final Score
70
Valuation > verdict
30.0% Undervalued
Profitability > metrics > ROE
-1.663265998940171
Profitability > metrics > ROA
-1.6446156010598205
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.011340277854795862
Risk > metrics > Interest Coverage
-19.598994974874373
Risk > final Score
-18
Risk > verdict
High
Liquidity > metrics > Current Ratio
207.61583740559752
Liquidity > metrics > Quick Ratio
207.61583740559752
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
43
Prev Risks > 1
54
Prev Risks > 2
-20
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
95
Updated At
2026-01-20T21:39:30.933Z
Earnings History > 0 > period
2026-01-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2026-01-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACRPF constable, wife arrested for alleged abuse of 10-year-old girl in Noida - The Economic Times
1/20/2026
CRPF constable, wife arrested for alleged abuse of 10-year-old girl in Noida The Economic Times
Read more →Watch: Son shares CRPF selection news at mother’s vegetable stall and the internet can’t stop crying odishatv.in
Read more →Showing 2 of 10
(Last Updated 2018-04-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Integrated Cannabis Company Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-01-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2018-04-30)
(Last Updated 2018-04-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2018-04-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2018-04-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.